Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -2.44
- Piotroski Score 3.00
- Grade Neutral
- Symbol (HLVX)
- Company HilleVax, Inc.
- Price $1.89
- Changes Percentage (-0.79%)
- Change -$0.02
- Day Low $1.86
- Day High $1.92
- Year High $20.22
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $32.00
- High Stock Price Target $34.00
- Low Stock Price Target $30.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.30
- Trailing P/E Ratio -4.1
- Forward P/E Ratio -4.1
- P/E Growth -4.1
- Net Income $-123,566,000
